Qingqing Yi serves as Non-Executive Independent Director of the Company. Mr. Yi is a Partner at Hillhouse Capital. He has worked with Hillhouse since the inception of the firm in 2005. Prior to joining Hillhouse, Mr. Yi was an Equity Research Analyst at China International Capital Corporation. Mr. Yi’s work at Hillhouse includes investments in the healthcare and consumer sectors in both its public and private equity portfolios. Mr. Yi received a B.S. degree in Engineering from Shanghai Maritime University in July 1995 and an MBA from University of Southern California in May 2003.
As the Non-Executive Independent Director of BeiGene Ltd, the total compensation of Qingqing YI at BeiGene Ltd is $371,000. There are 10 executives at BeiGene Ltd getting paid more, with John Oyler having the highest compensation of $13,899,000.
Qingqing YI is 48, he's been the Non-Executive Independent Director of BeiGene Ltd since 2014. There are 14 older and 6 younger executives at BeiGene Ltd. The oldest executive at BeiGene Ltd is Donald Glazer, 75, who is the Non-Executive Independent Director.
Qingqing's mailing address filed with the SEC is OFFICE #122, WINDWARD 3 BUILDING, REGATTA OFFICE PARK, GEORGE TOWN, GRAND CAYMAN, E9, KY1 1103.
Over the last 9 years, insiders at BeiGene Ltd have traded over $1,899,158,980 worth of BeiGene Ltd stock and bought 23,241,738 units worth $1,040,248,444 . The most active insiders traders include Bros. Advisors Lp667, L.P.B..., Investment Management, Ltd...., eBros. Advisors Lp Baker Bro.... On average, BeiGene Ltd executives and independent directors trade stock every 13 days with the average trade being worth of $33,382,815. The most recent stock trade was executed by Xiaobin Wu on 3 September 2024, trading 5,556 units of BGNE stock currently worth $1,053,695.
BeiGene is a biotechnology company that specializes in the development of drugs for cancer treatment. BeiGene has developed several pharmaceuticals, including tislelizumab, a checkpoint inhibitor, and zanubrutinib.
BeiGene Ltd executives and other stock owners filed with the SEC include: